Back to News

Netflix Embraces Generative AI for Visual Effects, Sparks Industry Debate

Analytics Insight
Jul 22, 2025 09:25
Bhavesh Maurya
1 views
aianalyticsbig-databusiness

Summary

Netflix is adopting generative AI tools to enhance its visual effects, aiming to streamline production and reduce costs. This move has sparked debate within the entertainment industry, raising concerns about job security for artists and the broader impact of AI on creative professions. The development highlights the growing influence of AI in media production and its potential to reshape industry workflows.

Read Full ArticleMore News

Related Articles

XRP vs Chainlink: Which Crypto Could Make You a Millionaire?

Analytics InsightJul 22

The article compares XRP and Chainlink, analyzing their potential to generate significant returns for investors. While primarily focused on cryptocurrency investment, it highlights how Chainlink’s AI-driven smart contract capabilities could play a pivotal role in the future of decentralized finance. This suggests that advancements in AI integration with blockchain technology may influence the success and adoption of such digital assets.

Skipped Early Cardano (ADA)? Don’t Miss Ruvi AI’s (RUVI) Audited Token While Still Cheap, Experts Say It’s Next to Rally

Analytics InsightJul 22

The article highlights Ruvi AI's (RUVI) audited token as a promising investment opportunity in the AI sector, drawing comparisons to the early days of Cardano (ADA). Experts suggest that RUVI's low current price and recent audit position it for significant growth, signaling increasing investor interest in AI-driven blockchain projects. This trend underscores the growing convergence of AI and blockchain technologies in the crypto market.

AI-Designed Drugs Can Target 'Undruggable' Proteins in Cancer and Alzheimer's

Hacker News - AIJul 22

AI-driven drug discovery is enabling the design of molecules that can target previously "undruggable" proteins involved in diseases like cancer and Alzheimer's. This breakthrough expands the range of treatable conditions and demonstrates AI's transformative potential in accelerating and broadening pharmaceutical innovation.